VLA 0.00% $1.75 viralytics limited

vla, page-23

  1. 2,005 Posts.
    lightbulb Created with Sketch. 123
    The big pharmas would want the competitive advantage and certainly dont want any stone un-turned. So in my opinion its a billion dollar industry and VLA would make a nice fit if controlled by a big pharma.
    As Keytruda gets more traction in the industry its obvious VLA's profile will be lifted with the joint research, so why not grab VLA while its cheap. I think VLA will be on their shopping list. It certainly would be on my radar if I was a big Pharma.
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.